Saturday, December 27, 2025
HomeTagsBiotechnology

Biotechnology

WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

WuXi Biologics, a global company with leading open-access biologics technology platforms, and ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology company in South Korea, announced that...

Biondvax Collaborates With Max Planck Institute and University Medical Center Göttingen for COVID-19 Therapeutics

BiondVax Pharmaceuticals Ltd. , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and...

Avacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™...

Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions

Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced the company has closed on a $31 million Series A financing. The round...

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

Exopharm Limited has been granted US patent US 11202805 for its LEAP exosome purification technology. This patent positions Exopharm as a global leader in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics